The Top Pharma Acquisitions of 2012 (AZN, BMY, GSK):
"Pharma largely backed off mergers and acquisitions this year, but there were still a couple of deals earning attention. Bristol-Myers Squibb (NYSE: BMY ) and AstraZeneca (NYSE: AZN ) made a significant diabetes play. GlaxoSmithKline (NYSE: GSK ) absorbed a pipeline partner with a small stable of drugs. The deals helped these big pharma players diversify their portfolio and offset revenues lost to patent expirations."
'via Blog this'
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Exemptee Institute
The Designated Representative Institute
Experts Aim to Use Brown Fat to Burn Fat More Effectively
38 minutes ago
No comments:
Post a Comment